Call for Science

Page

Abstract Submission

QICC 2026 invites original full papers or abstracts in cardiovascular medicine that have not been publicly published. Outstanding abstracts may be invited for oral presentation at the conference and selected submissions may be recommended to JACC for publication.

View → Page

Case Submission

QICC 2026 invites authentic and complete cardiovascular cases with diagnostic insight, technical value, difficult decision-making or multidisciplinary collaboration significance. Outstanding cases may be selected for presentation and exchange at the conference.

View → Page

Qianjiang Young Investigator (Clinical Medicine)

The 2026 Qianjiang Young Investigator program in clinical medicine is now open to young cardiovascular clinical researchers and physicians across China, inviting solid clinical thinking and innovative research perspectives to QICC 2026.

View → Page

Call for Late-Breaking Clinical Trials (LBCT)

The QICC 2026 Late-Breaking Clinical Trials (LBCT) Forum invites unpublished, high-impact cardiovascular clinical studies with significant scientific merit and clinical impact. Accepted LBCT submissions will be considered for simultaneous full-text publication in JACC or its leading subspecialty journals.

View →